What is NDC 62135-438?

62135-438 is the product NDC for Tricitrates, Potassium citrate 550 mg/5mL + 2 more ingredients solution, listed with the FDA by Chartwell RX, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.

What is the active ingredient?

Potassium citrate, Sodium citrate, Citric acid monohydrate.

Chartwell RX, LLC, NDC labeler code 62135. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Tricitrates?

2 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Tricitrates NDC 62135-438 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)62135-438Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62135-0438Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
62135-438-24	6213504382462135043824	2 TRAY in 1 BOX (62135-438-24) / 10 CUP in 1 TRAY / 5 mL in 1 CUP (62135-438-05)Marketed from Apr 15, 2025
62135-438-47	6213504384762135043847	473 mL in 1 BOTTLE (62135-438-47)Marketed from Dec 8, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Tricitrates
Generic name (nonproprietary): tricitrates
Active ingredients: Potassium citrate — 550 mg/5mLSodium citrate — 500 mg/5mLCitric acid monohydrate — 334 mg/5mL
Dosage form: Solution
Route: Oral
Labeler: Chartwell RX, LLCNDC labeler code 62135
Product type: Prescription drug
Marketing category: Unapproved drug (other)
Marketing start: Dec 8, 2022
Listing expires: Dec 31, 2026
Other FDA classes: Acidifying Activity (Mechanism)Acidifying Activity (Mechanism)Acidifying Activity (Mechanism)Calcium Chelating Activity (Mechanism)Calcium Chelating Activity (Mechanism)Calcium Chelating Activity (Mechanism)Decreased Coagulation Factor Activity (Physiologic effect)Decreased Coagulation Factor Activity (Physiologic effect)Decreased Coagulation Factor Activity (Physiologic effect)
Identifiers: Product ID 62135-438_33d7941b-0652-9528-e063-6394a90a8a55SPL ID 33d7941b-0652-9528-e063-6394a90a8a55SPL set ID 2a80ea6b-6334-4c33-a35e-a5cb2939fbcbRxCUI 309317UNII EE90ONI6FF, 1Q73Q2JULR, 2968PHW8QPUPC 0362135438470
Pharmacologic class: Anti-coagulant; Calculi Dissolution Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462135043824 followed by a unit qualifier and the quantity

Package 62135-0438-24. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 28, 2025.

Indications (excerpt from the label)

INDICATIONS AND ADVANTAGES Tricitrates oral solution is an effective alkalinizing agent useful in those conditions where long-term maintenance of an alkaline urine is desirable, such as in patients with uric acid and cystine calculi of the urinary tract. In addition, it is a valuable adjuvant when administered with uricosuric agents in gout therapy, since urates tend to crystallize out of an acid urine. It is also effective in correcting the acidosis of certain renal tubular disorders. This product is highly concentrated, and when administered after meals and before bedtime, allows one to maintain an alkaline urine pH around the clock, usually without the necessity of a 2 A.M. dose. This pro…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 62135-438

What is NDC 62135-438?: 62135-438 is the product NDC for Tricitrates, Potassium citrate 550 mg/5mL + 2 more ingredients solution, listed with the FDA by Chartwell RX, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Tricitrates.
What is the active ingredient?: Potassium citrate, Sodium citrate, Citric acid monohydrate.
Who is the labeler?: Chartwell RX, LLC, NDC labeler code 62135. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Tricitrates?: 2 other product NDCs are listed under this name. See all Tricitrates NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Tricitrates NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Tricitrates	Potassium citrate 550 mg/5mL + 2 more ingredients	SolutionOral	Chartwell Governmental & Specialty RX, LLC.	68999-438	68999-0438-24
Tricitratespotassium citrate, sodium citrate, and citric acid monohydrate	Potassium citrate 550 mg/5mL + 2 more ingredients	SolutionOral	PAI Holdings, LLC dba PAI Pharma	0121-0677	00121-0677-16